Immunogenic control of tumours and tumour cells

Details Immunogenic control of tumours and tumour cells Immunogenic control of tumours and tumour cells

A - Human Necessities

61

K

A61K 39/00 (2006.01) A61K 39/39 (2006.01) C07K 14/47 (2006.01) C12N 9/02 (2006.01)

Patent

CA 2715488

The present invention relates to the use of immunogenic peptides comprising a T-cell epitope derived from a tu-mour-associated antigen and a redox motif such as C-(X)2-[CST] or [CST]- (X)2-C in the treatment of a tumour or in the treat-ment or prevention of a tumour relapse, and in the manufacture of medicaments therefore.

La présente invention concerne l'utilisation de peptides immunogènes comprenant un épitope de lymphocyte T dérivé d'un antigène de vecteur viral et un motif redox tel que C-(X)2-[CST] ou [CST]-(X)2-C, d'une part pour le traitement d'une tumeur ou la prévention et/ou la suppression de la rechute tumorale, et d'autre part pour la fabrication de médicaments à cet effet.

Affiliated with

Also associated with

Rating

Immunogenic control of tumours and tumour cells does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Immunogenic control of tumours and tumour cells, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immunogenic control of tumours and tumour cells will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-2041611